Scholar Rock Holding Corporation (SRRK) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Scholar Rock (SRRK) Q1 2026: Dual Facility Strategy Secures Two Paths to SMA Launch Readiness
May 07, 2026
-
Scholar Rock (SRRK) Q4 2025: $550M Debt Facility Secured as SMA Launch Readiness Accelerates
March 03, 2026
-
Scholar Rock (SRRK) Q3 2025: $142M Capital Infusion Extends Runway as SMA Launch Hinges on Facility Remediation
November 14, 2025
-
Scholar Rock (SRRK) Q2 2025: September 22 PDUFA Sets Stage for SMA Launch Despite CDMO Observations
August 06, 2025
-
Scholar Rock (SRRK) Q1 2025: Priority Review Sets Up Epidegromab’s Q3 Launch for 35,000 SMA Patients
July 03, 2025